Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
OBJECTIVES: Thrombotic thrombocytopenic purpura (TTP) is a rare and devastating hematologic disorder frequently associated with multiple organ failure and sometimes death. This syndrome is mainly associated with severe deficiency of ADAMTS13, a disintegrin and metalloprotease with thrombospondin (TSP)-1 repeats, cleaving high molecular weight von Willebrand Factor (ULVWF) multimers. Decreased plasma ADAMTS13 activity results in the accumulation of ULVWF multimers with consequent platelet activation. Recently, obesity has been considered as a potential independent risk factor for TTP, but the reason of this association is still unknown.
METHODS AND RESULTS: We describe an unusual case of fatal recurrent TTP in a morbid obese female with non-alcoholic steatohepatitis (NASH) and severe ADAMTS13 activity deficiency due neither to an inhibitory autoantibody nor to a gene mutation.
CONCLUSIONS: Visceral obesity is associated with non-alcoholic fatty liver disease (NAFLD) and NASH: we hypothesized that these conditions can influence ADAMTS13 antigen and activity. In fact, hepatic stellate cells (HSC) are the main producers of ADAMTS13, and a decrease in ADAMTS13 activity has been reported in liver disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
---|---|
Enthalten in: |
European journal of haematology - 92(2014), 6 vom: 24. Juni, Seite 497-501 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lombardi, Anna Maria [VerfasserIn] |
---|
Links: |
---|
Themen: |
ADAM Proteins |
---|
Anmerkungen: |
Date Completed 06.01.2015 Date Revised 25.11.2016 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/ejh.12273 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM234816988 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM234816988 | ||
003 | DE-627 | ||
005 | 20231224102056.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/ejh.12273 |2 doi | |
028 | 5 | 2 | |a pubmed24n0782.xml |
035 | |a (DE-627)NLM234816988 | ||
035 | |a (NLM)24460705 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lombardi, Anna Maria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.01.2015 | ||
500 | |a Date Revised 25.11.2016 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
520 | |a OBJECTIVES: Thrombotic thrombocytopenic purpura (TTP) is a rare and devastating hematologic disorder frequently associated with multiple organ failure and sometimes death. This syndrome is mainly associated with severe deficiency of ADAMTS13, a disintegrin and metalloprotease with thrombospondin (TSP)-1 repeats, cleaving high molecular weight von Willebrand Factor (ULVWF) multimers. Decreased plasma ADAMTS13 activity results in the accumulation of ULVWF multimers with consequent platelet activation. Recently, obesity has been considered as a potential independent risk factor for TTP, but the reason of this association is still unknown | ||
520 | |a METHODS AND RESULTS: We describe an unusual case of fatal recurrent TTP in a morbid obese female with non-alcoholic steatohepatitis (NASH) and severe ADAMTS13 activity deficiency due neither to an inhibitory autoantibody nor to a gene mutation | ||
520 | |a CONCLUSIONS: Visceral obesity is associated with non-alcoholic fatty liver disease (NAFLD) and NASH: we hypothesized that these conditions can influence ADAMTS13 antigen and activity. In fact, hepatic stellate cells (HSC) are the main producers of ADAMTS13, and a decrease in ADAMTS13 activity has been reported in liver disease | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a ADAMTS13 | |
650 | 4 | |a non-alcoholic steatohepatitis | |
650 | 4 | |a obesity | |
650 | 4 | |a thrombotic thrombocytopenic purpura | |
650 | 7 | |a ADAM Proteins |2 NLM | |
650 | 7 | |a EC 3.4.24.- |2 NLM | |
650 | 7 | |a ADAMTS13 Protein |2 NLM | |
650 | 7 | |a EC 3.4.24.87 |2 NLM | |
650 | 7 | |a ADAMTS13 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.24.87 |2 NLM | |
700 | 1 | |a Fabris, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Berti de Marinis, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Marson, Piero |e verfasserin |4 aut | |
700 | 1 | |a Navaglia, Filippo |e verfasserin |4 aut | |
700 | 1 | |a Plebani, Mario |e verfasserin |4 aut | |
700 | 1 | |a Vettor, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Fabris, Fabrizio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of haematology |d 1990 |g 92(2014), 6 vom: 24. Juni, Seite 497-501 |w (DE-627)NLM01261727X |x 1600-0609 |7 nnns |
773 | 1 | 8 | |g volume:92 |g year:2014 |g number:6 |g day:24 |g month:06 |g pages:497-501 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/ejh.12273 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 92 |j 2014 |e 6 |b 24 |c 06 |h 497-501 |